EXCLUSIVE: Novo Nordisk Faces Political Pressure Over Weight Loss Drug Pricing Ahead of Election, But ‘Real Problem Is with the Middlemen’ – Novo Nordisk (NYSE:NVO), Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS) – Benzinga

by
  1. EXCLUSIVE: Novo Nordisk faces political pressure over weight-loss drug prices ahead of election, but ‘the real problem is with the middlemen’ – Novo Nordisk (NYSE:NVO), Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS)Benzinga
  2. Senators pressure Novo Nordisk CEO on why Ozempic and Wegovy cost less abroadThe Washington Post
  3. ‘Stop ripping us off’: Senate questions Novo Nordisk CEO over price of weight-loss drugsCNBC
  4. Why does Ozempic cost so much? Senators question Novo Nordisk CEO for answers.USA TODAY
  5. Elon Musk and Bernie Sanders say they agree on one thing: cheaper OzempicFortune

Leave a Comment